A paper by Hiroshi Kiyono’s and Kohtaro Fujihashi ‘s group (Division of Mucosal Vaccine) was published in Vaccine.
2022年5月26日
A paper by Hiroshi Kiyono’s and Kohtaro Fujihashi ‘s group (Division of Mucosal Vaccine) was published in Vaccine.
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults
Yuki Y, Nojima M, Kashima K, Sugiura K, Maruyama S, Kurokawa S, Yamanoue T, Nakahashi-Ouchida R, Nakajima H, Hiraizumi T, Kohno H, Goto E, Fujihashi K, Kiyono H
Vaccine. 2022 May 26;40(24):3372-3379. doi: 10.1016/j.vaccine.2022.04.051. Epub 2022 Apr 26.